These studies were extended to include isolated glomeruli, and incubation with recombinant VEGF-A165b was associated with reduced permeability in human glomeruli from patients with diabetic nephropathy, raising the prospects of a therapeutic application for this protective VEGF-A isoform. The gene discussed is VEGFA; the disease is diabetic kidney disease.